Statistical analysis of shape through triangulation of landmarks: A study of sexual dimorphism in hominids

Por Rao, Calyampudi R., Suryawanshi, Shailaja
Publicado em 1998

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Por Gantz, Ira, Chen, Menghui, Suryawanshi, Shailaja, Ntabadde, Catherine, Shah, Sukrut, O’Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Lai, Eseng
Publicado no Cardiovasc Diabetol (2017)

One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures

Por Kolotkin, Ronette L, Norquist, Josephine M, Crosby, Ross D, Suryawanshi, Shailaja, Teixeira, Pedro J, Heymsfield, Steven B, Erondu, Ngozi, Nguyen, Allison M
Publicado em 2009

Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibito...

Por Goldenberg, Ronald, Gantz, Ira, Andryuk, Paula J., O'Neill, Edward A., Kaufman, Keith D., Lai, Eseng, Wang, Yin Na, Suryawanshi, Shailaja, Engel, Samuel S.
Publicado no Diabetes Obes Metab (2017)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequ...

Por Lee, Seung-Hwan, Gantz, Ira, Round, Elizabeth, Latham, Melanie, O’Neill, Edward A., Ceesay, Paulette, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no BMC Endocr Disord (2017)